Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same
US7939072B2 · kind B2 · utility
33Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2009 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Jan 21, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of identifying a combination of antibodies with a combined improved anti tumor activity is provided. The method comprising identifying at least two anti RTK antibodies capable of inducing synergistic endocytosis of the RTK in a cell expressing the RTK, thereby identifying the combination of antibodies with the combined improved anti-tumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.